Cell-based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits, Instrument & Software, Services), Application (Drug Discovery, Research), End User (CROs, Pharmaceutical Companies, Research Institutes) - Global Forecast to 2025

世界のセルベースアッセイ市場予測:製品・サービス別、用途別、エンドユーザー別

◆タイトル:Cell-based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits, Instrument & Software, Services), Application (Drug Discovery, Research), End User (CROs, Pharmaceutical Companies, Research Institutes) - Global Forecast to 2025
◆商品コード:BT2486
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年3月19日
◆ページ数:231
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界のセルベースアッセイ市場規模が2020年149億ドルから2025年220億ドルまで、年平均8.1%成長すると予測しています。本調査資料では、セルベースアッセイの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(消耗品、機器・ソフトウェア、サービス)分析、用途別(創薬、研究、その他)分析、エンドユーザー別(医薬品・バイオ医薬品、委託研究機関、学術・研究機関)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のセルベースアッセイ市場規模:製品・サービス別(消耗品、機器・ソフトウェア、サービス)
・世界のセルベースアッセイ市場規模:用途別(創薬、研究、その他)
・世界のセルベースアッセイ市場規模:エンドユーザー別(医薬品・バイオ医薬品、委託研究機関、学術・研究機関)
・世界のセルベースアッセイ市場規模:地域別
・競争状況
・企業情報

“The cell-based assays market is projected to reach USD 22.0 billion by 2025 from USD 14.9 billion in 2020, at a CAGR of 8.1% during the forecast period.”
The growing preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market.

“By product and service, the consumables segment accounted for the largest share of the cell-based assays market”
The cell-based assays market is categorized into major three product and service categories, consuambles, instrumenet & software and services. Consumables dominated the market in 2019. The large share of this segment can be attributed to the extensive use and repeated purchase of consumables by pharmaceutical and biopharmaceutical companies and the rising number of preliminary studies for the development of therapeutics.

“Asia Pacific: The fastest-growing region in the cell-based assays market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the government initiatives to increase funding in biopharmaceuticals, growing R&D spending, and partnerships for life science research.

“North America: the largest share of the cell-based assays market”
North America accounted for the largest share of the cell-based assays market. Factors such as the to the availability of government and private funding for life science research, the growing penetration of CROs, comprehensive drug development regulations, and the rapid adoption of advanced technologies in the region are the major factors driving the market growth.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
By Respondent– Supply Side- 70%, Demand Side- 30%
By Designation— Executives- 25%, CXOs, Directors- 20%, Managers – 55%
By Region— North America – 50%, Europe – 20%, APAC – 20%, LATAM- 5%, MEA- 5%

The cell-based assays market is dominated by a few globally established players such as Becton, Dickinson and Company (US), Cell Signaling Technology, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), PerkinElmer, Inc. (US), Promega Corporation (US), Charles River Laboratories (US), Lonza (Switzerland), BioAgilytix Labs (US), Reaction Biology Corporation (US), AAT Bioquest (US), IBR Inc. (Switzerland), PBL Assay Science (US), Eurofins (US), InvivoGen (US), TopoGEN, Inc. (US), Ca3 Bioscience (Neuromics) (US), Cell Biolabs, Inc. (US), Carna Biosciences, Inc. (Japan), Dojindo Molecular Technologies, Inc. (US), Enzo Life Sciences, Inc. (US), BPS Bioscience, Inc. (US), SGS SA (Switzerland), and MLM Medical Laboratories (MD Biosciences) (US).

Research Coverage:
The report segments the cell-based assays market based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), Consumables (Reagents, Assay Kits (Reporter Gene Assays, Second Messenger Assays, Cell Growth Assays, Cell Death Assays, Other Assay Kits), Cell Lines (Immortalized Cell Lines, Primary Cell Lines, Stem Cell Lines), Microplates, Probes & Labels, Other Consumables), Instruments & Software, Services, Application (Drug Discovery (Pharmacodynamic Studies, Pharmacokinetic Studies, Toxicity Studies), Basic Research and Other Application), End users (Pharmaceutical & Biopharmaceutical Companies, CROs, and Academic & Research Institutes).

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the cell-based assays market

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the cell-based assays market and provides them information on key market drivers, challenges, and opportunities

【レポートの目次】

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS AND EXCLUSIONS 31
1.3 STUDY SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 YEARS CONSIDERED FOR THE STUDY 32
1.4 CURRENCY USED FOR THE STUDY 32
1.5 LIMITATIONS 32
1.6 MARKET STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 33
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
2.1.1 SECONDARY DATA 35
2.1.2 PRIMARY DATA 36
FIGURE 1 PRIMARY SOURCES 36
FIGURE 2 CELL-BASED ASSAYS MARKET: BREAKDOWN OF PRIMARIES 37
2.2 MARKET SIZE ESTIMATION 38
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 – REVENUE SHARE ANALYSIS, 2019 38
FIGURE 4 AVERAGE MARKET SIZE ESTIMATION, 2019 39
FIGURE 5 CELL-BASED ASSAYS MARKET: CAGR PROJECTIONS, 2020–2025 40
FIGURE 6 CELL-BASED ASSAYS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES 40
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 7 DATA TRIANGULATION METHODOLOGY 42
2.4 RESEARCH ASSUMPTIONS 43
2.5 RISK ANALYSIS 43
3 EXECUTIVE SUMMARY 44
FIGURE 8 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 44
FIGURE 9 CELL-BASED ASSAYS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 45
FIGURE 10 CELL-BASED ASSAYS MARKET, BY END USER (USD MILLION) 45
FIGURE 11 GEOGRAPHICAL SNAPSHOT: CELL-BASED ASSAYS MARKET 46

4 PREMIUM INSIGHTS 47
4.1 CELL-BASED ASSAYS MARKET OVERVIEW 47
FIGURE 12 RISING DRUG DISCOVERY ACTIVITY IS DRIVING THE DEMAND FOR CELL-BASED ASSAYS 47
4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET SHARE (2019) 48
FIGURE 13 CONSUMABLES COMMANDED THE LARGEST SHARE OF THE NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2019 48
4.3 CELL-BASED ASSAYS MARKET SHARE, BY APPLICATION (2019) 48
FIGURE 14 DRUG DISCOVERY COMMANDED THE LARGEST SHARE OF THE CELL-BASED ASSAYS MARKET IN 2019 48
4.4 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
FIGURE 15 CHINA IS THE FASTEST-GROWING MARKET FOR CELL-BASED ASSAYS 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
FIGURE 16 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 50
5.2.1 DRIVERS 50
5.2.1.1 Growing preference for cell-based assays in drug discovery 50
5.2.1.2 Increasing funding for cell-based research 51
5.2.1.3 Growth in the number of drug discovery activities 51
5.2.2 RESTRAINTS 52
5.2.2.1 High cost of instruments and restrictions on reagent use 52
5.2.2.2 Lack of infrastructure for cell-based research in emerging economies 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Emerging economies 52
5.2.3.2 Growing risk of pandemics and communicable diseases 52
5.2.3.3 Application of novel cell-based assays in cancer research 53
5.3 IMPACT OF COVID-19 ON THE CELL-BASED ASSAYS MARKET 53
5.4 VALUE CHAIN ANALYSIS 54
FIGURE 17 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS 54
5.5 SUPPLY CHAIN ANALYSIS 55
FIGURE 18 CELL-BASED ASSAYS MARKET: SUPPLY CHAIN ANALYSIS 56
5.6 ECOSYSTEM ANALYSIS 56
FIGURE 19 CELL-BASED ASSAYS MARKET: ECOSYSTEM ANALYSIS 56
6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE 57
6.1 INTRODUCTION 58
TABLE 1 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 58
6.2 CONSUMABLES 58
TABLE 2 CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION) 59
TABLE 3 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 59
TABLE 4 EUROPE: CONSUMABLES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 59
TABLE 5 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 60
TABLE 6 CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 60
6.2.1 REAGENTS 60
6.2.1.1 Expanded applications of reagents propel market growth for the segment 60
TABLE 7 REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 8 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 61
TABLE 9 EUROPE: REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 62
TABLE 10 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 62
6.2.2 ASSAY KITS 62
TABLE 11 ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION) 63
TABLE 12 NORTH AMERICA: ASSAY KITS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 63
TABLE 13 EUROPE: ASSAY KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 64
TABLE 14 ASIA PACIFIC: ASSAY KITS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 64
TABLE 15 ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 65
6.2.2.1 Reporter gene assays 65
6.2.2.1.1 Reporter gene assays can be used with limited resources to establish HTS platforms, representing opportunities for small laboratories with limited resources 65
TABLE 16 REPORTER GENE ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION) 66
TABLE 17 NORTH AMERICA: REPORTER GENE ASSAYS REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 66
TABLE 18 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 66
TABLE 19 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 67
6.2.2.2 Cell growth assays 67
6.2.2.2.1 Cell viability and cell proliferation assays are the two most important in vitro quantification techniques for assessing cell growth 67
TABLE 20 CELL GROWTH ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION) 68
TABLE 21 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 68
TABLE 22 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 68
TABLE 23 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 69
6.2.2.3 Second messenger assays 69
6.2.2.3.1 These assays are used to detect and characterize all compound classes 69
TABLE 24 SECOND MESSENGER ASSAYS MARKET, BY REGION,
2018–2025 (USD MILLION) 69
TABLE 25 NORTH AMERICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 70
TABLE 26 EUROPE: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 70
TABLE 27 ASIA PACIFIC: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 71
6.2.2.4 Cell death assays 71
6.2.2.4.1 Cell death quantification is essential to identify how potential drugs could inhibit or enhance molecular targets 71
TABLE 28 CELL DEATH ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION) 72
TABLE 29 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 72
TABLE 30 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 72
TABLE 31 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 73
6.2.2.5 Other assay kits 73
TABLE 32 OTHER ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION) 74
TABLE 33 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 74
TABLE 34 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 74
TABLE 35 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 75
6.2.3 MICROPLATES 75
6.2.3.1 Extensive use of microplates for assay development is encouraging the consumption of these products 75
TABLE 36 MICROPLATES MARKET, BY REGION, 2018–2025 (USD MILLION) 76
TABLE 37 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 76
TABLE 38 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 39 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 77
6.2.4 CELL LINES 77
TABLE 40 CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION) 77
TABLE 41 NORTH AMERICA: CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 78
TABLE 42 EUROPE: CELL LINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 43 ASIA PACIFIC: CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 78
TABLE 44 CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 79
6.2.4.1 Immortalized cell lines 79
6.2.4.1.1 Immortalized cell lines are widely used owing to their ease of use, cost-effectiveness, and high availability of material 79
TABLE 45 IMMORTALIZED CELL LINES MARKET, BY REGION,
2018–2025 (USD MILLION) 79
TABLE 46 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 80
TABLE 47 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 80
TABLE 48 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 80
6.2.4.2 Primary cell lines 81
6.2.4.2.1 Primary cell lines find demand in a range of applications 81
TABLE 49 PRIMARY CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION) 81
TABLE 50 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 81
TABLE 51 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 82
TABLE 52 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 82
6.2.4.3 Stem cell lines 82
6.2.4.3.1 Stem cell lines find applications in therapy development and regenerative medicine 82
TABLE 53 STEM CELL LINES MARKET, BY REGION, 2018–2025 (USD MILLION) 83
TABLE 54 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 83
TABLE 55 EUROPE: STEM CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 83
TABLE 56 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 84
6.2.5 PROBES & LABELS 84
6.2.5.1 Effective labeling of cells helps in studying cellular events 84
TABLE 57 PROBES & LABELS MARKET, BY REGION, 2018–2025 (USD MILLION) 84
TABLE 58 NORTH AMERICA: PROBES & LABELS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 85
TABLE 59 EUROPE: PROBES & LABELS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 85
TABLE 60 ASIA PACIFIC: PROBES & LABELS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 85
6.2.6 OTHER CONSUMABLES 86
TABLE 61 OTHER CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION) 86
TABLE 62 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 86
TABLE 63 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 87
TABLE 64 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 87

6.3 INSTRUMENTS & SOFTWARE 88
6.3.1 TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION IN INSTRUMENTS AND RISING USE OF SOFTWARE DRIVE THE GROWTH OF THE SEGMENT 88
TABLE 65 INSTRUMENTS & SOFTWARE MARKET, BY REGION,
2018–2025 (USD MILLION) 89
TABLE 66 NORTH AMERICA: INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 89
TABLE 67 EUROPE: INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 90
TABLE 68 ASIA PACIFIC: INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 90
6.4 SERVICES 91
6.4.1 RISING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE SEGMENT GROWTH 91
TABLE 69 SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 91
TABLE 70 NORTH AMERICA: SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 92
TABLE 71 EUROPE: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 92
TABLE 72 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 92
7 CELL-BASED ASSAYS MARKET, BY APPLICATION 93
7.1 INTRODUCTION 94
TABLE 73 GLOBAL CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 94
7.2 DRUG DISCOVERY 94
TABLE 74 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 95
TABLE 75 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 95
TABLE 76 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 77 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 78 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION) 97
7.2.1 TOXICITY STUDIES 97
7.2.1.1 Increasing adoption of high-content screening for cytotoxicity testing to fuel growth in this segment 97
TABLE 79 TOXICITY STUDIES MARKET, BY REGION, 2018–2025 (USD MILLION) 98
TABLE 80 NORTH AMERICA: TOXICITY STUDIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 98
TABLE 81 EUROPE: TOXICITY STUDIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 98
TABLE 82 ASIA PACIFIC: TOXICITY STUDIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 99
7.2.2 PHARMACOKINETIC STUDIES 99
7.2.2.1 Rising importance of ADME studies in pharmacokinetics to propel the demand for advanced cell-based assay technologies 99
TABLE 83 PHARMACOKINETIC STUDIES MARKET, BY REGION,
2018–2025 (USD MILLION) 100
TABLE 84 NORTH AMERICA: PHARMACOKINETIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 100
TABLE 85 EUROPE: PHARMACOKINETIC STUDIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 101
TABLE 86 ASIA PACIFIC: PHARMACOKINETIC STUDIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 101
7.2.3 PHARMACODYNAMIC STUDIES 102
7.2.3.1 Expanded use of cell-based assays to study pharmacodynamics to propel the growth of the segment 102
TABLE 87 PHARMACODYNAMIC STUDIES MARKET, BY REGION,
2018–2025 (USD MILLION) 102
TABLE 88 NORTH AMERICA: PHARMACODYNAMIC STUDIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 103
TABLE 89 EUROPE: PHARMACODYNAMIC STUDIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 103
TABLE 90 ASIA PACIFIC: PHARMACODYNAMIC STUDIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 104
7.3 BASIC RESEARCH 104
7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE THE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES 104
TABLE 91 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 105
TABLE 92 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 105
TABLE 93 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 106
TABLE 94 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 106
7.4 OTHER APPLICATIONS 106
TABLE 95 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 107
TABLE 96 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 107
TABLE 97 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2018–2025 (USD MILLION) 108
TABLE 98 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2018–2025 (USD MILLION) 108
8 CELL-BASED ASSAYS MARKET, BY END USER 109
8.1 INTRODUCTION 110
TABLE 99 CELL-BASED ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION) 110
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 110
8.2.1 GROWING R&D ACTIVITIES TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT 110
TABLE 100 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION) 111
TABLE 101 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,
2018–2025 (USD MILLION) 111
TABLE 102 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,
2018–2025 (USD MILLION) 112
TABLE 103 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,
2018–2025 (USD MILLION) 112
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) 112
8.3.1 GROWTH IN OUTSOURCING TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS 112
TABLE 104 RECENT MERGERS & ACQUISITIONS AMONG CONTRACT RESEARCH ORGANIZATIONS 113
TABLE 105 CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION) 114
TABLE 106 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 114
TABLE 107 EUROPE: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 115
TABLE 108 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 115
8.4 ACADEMIC & RESEARCH INSTITUTES 116
8.4.1 GROWING FOCUS OF ACADEMIC INSTITUTIONS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT 116
TABLE 109 CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 116
TABLE 110 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 117
TABLE 111 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 117
TABLE 112 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 118
9 CELL-BASED ASSAYS MARKET, BY REGION 119
9.1 INTRODUCTION 120
TABLE 113 CELL-BASED ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION) 120
9.2 NORTH AMERICA 120
FIGURE 20 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT 121
TABLE 114 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 122
TABLE 115 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 122
TABLE 116 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 117 NORTH AMERICA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 118 NORTH AMERICA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 119 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 123
TABLE 120 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 124
TABLE 121 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 124
9.2.1 US 124
9.2.1.1 With growing R&D funding and recent drug approvals, the US dominates the North American cell-based assays market 124
TABLE 122 US: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 125
TABLE 123 US: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 125
TABLE 124 US: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 126
TABLE 125 US: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 126
TABLE 126 US: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 126
TABLE 127 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 128 US: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 127
9.2.2 CANADA 127
9.2.2.1 Strategic partnerships and collaborations are supporting the growth of the market in Canada 127
TABLE 129 CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 128
TABLE 130 CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 128
TABLE 131 CANADA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 132 CANADA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 133 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 129
TABLE 134 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 130
TABLE 135 CANADA: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 130
9.3 EUROPE 130
TABLE 136 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 131
TABLE 137 EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 131
TABLE 138 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 132
TABLE 139 EUROPE: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 132
TABLE 140 EUROPE: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 133
TABLE 141 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 133
TABLE 142 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 133
TABLE 143 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 134
9.3.1 GERMANY 134
9.3.1.1 Germany dominates the cell-based assays market in Europe 134
TABLE 144 GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 135
TABLE 145 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 135
TABLE 146 GERMANY: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 147 GERMANY: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 148 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 136
TABLE 149 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 137
TABLE 150 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 137
9.3.2 UK 137
9.3.2.1 Focus on cancer research funding will increase the demand for cell-based assays in the country 137
TABLE 151 UK: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 138
TABLE 152 UK: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 138
TABLE 153 UK: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 139
TABLE 154 UK: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 139
TABLE 155 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 139
TABLE 156 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION) 140
TABLE 157 UK: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 140
9.3.3 FRANCE 140
9.3.3.1 Increase in R&D funding to drive the growth of the market 140
TABLE 158 FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 141
TABLE 159 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 141
TABLE 160 FRANCE: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 161 FRANCE: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 142
TABLE 162 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 142
TABLE 163 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 143
TABLE 164 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 143
9.3.4 ITALY 143
9.3.4.1 Strategic collaborations in drug discovery have promoted the growth of the cell-based assays market in Italy 143
TABLE 165 ITALY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 144
TABLE 166 ITALY: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 144
TABLE 167 ITALY: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 145
TABLE 168 ITALY: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 145
TABLE 169 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 145
TABLE 170 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 146
TABLE 171 ITALY: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 146
9.3.5 SPAIN 146
9.3.5.1 Availability of funding from private and public organizations is aiding the market growth 146
TABLE 172 SPAIN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 147
TABLE 173 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 147
TABLE 174 SPAIN: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 148
TABLE 175 SPAIN: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 148
TABLE 176 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 148
TABLE 177 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 149
TABLE 178 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 149
9.3.6 REST OF EUROPE 149
TABLE 179 ROE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 150
TABLE 180 ROE: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 150
TABLE 181 ROE: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 151
TABLE 182 ROE: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 151
TABLE 183 ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 151
TABLE 184 ROE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 152
TABLE 185 ROE: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 152
9.4 ASIA PACIFIC 153
FIGURE 21 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT 153
TABLE 186 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 154
TABLE 187 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 154
TABLE 188 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE,
2018–2025 (USD MILLION) 154
TABLE 189 ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 155
TABLE 190 ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 155
TABLE 191 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 155
TABLE 192 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 156
TABLE 193 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 156
9.4.1 CHINA 156
9.4.1.1 Rising R&D capabilities and accelerated drug discovery have created a demand for cell-based assays products and services 156
TABLE 194 CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 157
TABLE 195 CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 157
TABLE 196 CHINA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 158
TABLE 197 CHINA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 158
TABLE 198 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 158
TABLE 199 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 159
TABLE 200 CHINA: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 159
9.4.2 JAPAN 159
9.4.2.1 Government programs to encourage drug discovery has increased the demand for cell-based assays in Japan 159
TABLE 201 JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 160
TABLE 202 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 160
TABLE 203 JAPAN: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 161
TABLE 204 JAPAN: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 161
TABLE 205 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 161
TABLE 206 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 162
TABLE 207 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 162
9.4.3 INDIA 162
9.4.3.1 Market growth in India is attributed to increasing investments in R&D and funding for life sciences research 162
TABLE 208 INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 163
TABLE 209 INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 163
TABLE 210 INDIA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 164
TABLE 211 INDIA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 164
TABLE 212 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 164
TABLE 213 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 165
TABLE 214 INDIA: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 165
9.4.4 REST OF ASIA PACIFIC 165
TABLE 215 ROAPAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 166
TABLE 216 ROAPAC: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 166
TABLE 217 ROAPAC: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 167
TABLE 218 ROAPAC: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 167
TABLE 219 ROAPAC: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 167
TABLE 220 ROAPAC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 168
TABLE 221 ROAPAC: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 168
9.5 LATIN AMERICA 168
9.5.1 RISING NUMBER OF CLINICAL TRIAL SITES AND GROWING PARTICIPATION OF ACADEMIC INSTITUTES IN RESEARCH TO ACCELERATE MARKET GROWTH 168
TABLE 222 LATAM: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 169
TABLE 223 LATAM: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 169
TABLE 224 LATAM: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 170
TABLE 225 LATAM: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 170
TABLE 226 LATAM: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 170
TABLE 227 LATAM: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 171
TABLE 228 LATAM: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 171
9.6 MIDDLE EAST & AFRICA 171
9.6.1 GOVERNMENT EFFORTS TO INCREASE RESEARCH WILL FUEL THE DEMAND FOR CELL-BASED ASSAYS IN THE REGION 171
TABLE 229 MEA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2018–2025 (USD MILLION) 172
TABLE 230 MEA: CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION) 172
TABLE 231 MEA: ASSAY KITS MARKET, BY TYPE, 2018–2025 (USD MILLION) 173
TABLE 232 MEA: CELL LINES MARKET, BY TYPE, 2018–2025 (USD MILLION) 173
TABLE 233 MEA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 173
TABLE 234 MEA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 174
TABLE 235 MEA: CELL-BASED ASSAYS MARKET, BY END USER,
2018–2025 (USD MILLION) 174
10 COMPETITIVE LANDSCAPE 175
10.1 OVERVIEW 175
FIGURE 22 MARKET EVALUATION FRAMEWORK 175
10.2 REVENUE ANALYSIS OF TOP MARKET PLAYERS 176
FIGURE 23 MARKET SHARE ANALYSIS: 2019 176
TABLE 236 CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 177
10.3 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION QUADRANT, 2019 177
10.3.1 STARS 178
10.3.2 EMERGING LEADERS 178
10.3.3 PERVASIVE COMPANIES 178
10.3.4 EMERGING COMPANIES 178
FIGURE 24 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX, 2019 179
10.4 CELL-BASED ASSAYS MARKET: START-UP/SME EVALUATION MATRIX, 2019 180
10.4.1 PROGRESSIVE COMPANIES 180
10.4.2 STARTING BLOCKS 180
10.4.3 RESPONSIVE COMPANIES 180
10.4.4 DYNAMIC COMPANIES 180
FIGURE 25 CELL-BASED ASSAYS MARKET: STARTUP/SME EVALUATION MATRIX, 2019 181
10.5 KEY MARKET DEVELOPMENTS 182
10.5.1 KEY PRODUCT LAUNCHES 182
10.5.2 KEY ACQUISITIONS 182
10.5.3 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 183
10.5.4 KEY EXPANSIONS 183
11 COMPANY PROFILES 184
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
11.1 THERMO FISHER SCIENTIFIC 184
FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 184
11.2 DANAHER CORPORATION 189
FIGURE 27 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 189
11.3 MERCK KGAA 195
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2019) 195
11.4 BECTON, DICKINSON AND COMPANY 199
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 199
11.5 LONZA GROUP 202
FIGURE 30 LONZA GROUP AG: COMPANY SNAPSHOT 202
11.6 PERKINELMER 204
FIGURE 31 PERKINELMER: COMPANY SNAPSHOT (2019) 204
11.7 CHARLES RIVER LABORATORIES 207
FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2019) 207
11.8 EUROFINS SCIENTIFIC SE 210
FIGURE 33 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2019) 210
11.9 ENZO BIOCHEM 213
FIGURE 34 ENZO BIOCHEM: COMPANY SNAPSHOT (2019) 213
11.10 PROMEGA CORPORATION 216
11.11 CARNA BIOSCIENCES, INC. 218
FIGURE 35 CARNA BIOSCIENCES: COMPANY SNAPSHOT (2020) 218
11.12 CELL BIOLABS 221
11.13 CELL SIGNALING TECHNOLOGY 223
11.14 BIOAGILYTIX LABS INC. 224
11.15 REACTION BIOLOGY CORPORATION 225
11.16 AAT BIOQUEST, INC. 227
11.17 PBL ASSAY SCIENCE 229
11.18 INVIVOGEN 230
11.19 CA3 BIOSCIENCES INC. (NEUROMICS) 231
11.20 BPS BIOSCIENCE 232
*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX 233
12.1 DISCUSSION GUIDE 233
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 236
12.3 AVAILABLE CUSTOMIZATIONS 238
12.4 RELATED REPORTS 238
12.5 AUTHOR DETAILS 239



★調査レポート[世界のセルベースアッセイ市場予測:製品・サービス別、用途別、エンドユーザー別] ( Cell-based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits, Instrument & Software, Services), Application (Drug Discovery, Research), End User (CROs, Pharmaceutical Companies, Research Institutes) - Global Forecast to 2025 / BT2486) 販売に関する免責事項
[世界のセルベースアッセイ市場予測:製品・サービス別、用途別、エンドユーザー別] ( Cell-based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits, Instrument & Software, Services), Application (Drug Discovery, Research), End User (CROs, Pharmaceutical Companies, Research Institutes) - Global Forecast to 2025 / BT2486) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆